investordatabase.org

Novartis Venture Fund

nvfund.com Direct investor

Novartis Venture Fund is a corporate venture fund that invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages. It manages over USD 750 million in committed capital and has more than 40 portfolio companies across North America and Europe.

Novartis Venture Fund is a corporate venture arm headquartered in Basel, Switzerland. It invests directly in companies, from seed to growth, in biotechnology, biopharmaceuticals, life sciences and healthcare. USD 750 million under management and 40 portfolio companies, as it reports.

“We’re investing in the future health of patients worldwide”

Novartis Venture Fund, own website
Layer
Direct investor
Type
Corporate venture
Stage
SeedGrowth
Headquarters
Basel, Switzerland
Invests in
North America, Europe
Sectors
biotechnology, biopharmaceuticals, life sciences, healthcare, therapeutics, drug development
Assets under management
USD 750 million
Portfolio
40 companies

Co-invests most often with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 39 co-investors found.

and 29 more — the graph.

Where this comes from

Every fact above was read from a page Novartis Venture Fund publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

  • https://www.nvfund.com/name, is_investor, layer, type, hq_country, hq_city, invests_in_geographies, stage_min, stage_max, sectors, thesis_quote, thesis_quote_page, description, aum, portfolio_count, status, confidence

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 1199 · added 2026-08-28 · link last verified 2026-09-06 · confidence high

Similar investors

Listed under